3rd Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)

LobbyistCovered position, as disclosed
JAMES HUNTER —
JAMES RAVITZ —
DAN RENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2810 (113th), S. 1871 (113th)

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products

LobbyistCovered position, as disclosed
JAMES RAVITZ —
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.